https://www.barrons.com/articles/gilead-stock-buy-upgrade-e5ff33a3
0
0
9/8/23 at 3:20pm
Organization
Barron's
Author
Emily Dattilo
30 words
0
Comments
BofA upgraded shares of biotech Gilead to Buy from Neutral, and lifted the target price to $95 from $88.
You are the first to view
Create an account
or login to join the discussion